Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Raymond James Financial (RJF) Cash & Equivalents (2016 - 2026)

Raymond James Financial filings provide 17 years of Cash & Equivalents readings, the most recent being $9.9 billion for Q4 2025.

  • On a quarterly basis, Cash & Equivalents fell 1.57% to $9.9 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $9.9 billion, a 1.57% decrease, with the full-year FY2025 number at $11.4 billion, down 20.62% from a year prior.
  • Cash & Equivalents hit $9.9 billion in Q4 2025 for Raymond James Financial, down from $11.4 billion in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $16.4 billion in Q3 2021 to a low of $5.7 billion in Q1 2022.
  • Median Cash & Equivalents over the past 5 years was $9.3 billion (2023), compared with a mean of $9.5 billion.
  • The widest YoY moves for Cash & Equivalents: up 70.74% in 2021, down 45.05% in 2021.
  • Raymond James Financial's Cash & Equivalents stood at $8.2 billion in 2021, then decreased by 24.82% to $6.2 billion in 2022, then skyrocketed by 65.23% to $10.2 billion in 2023, then dropped by 1.55% to $10.0 billion in 2024, then fell by 1.57% to $9.9 billion in 2025.
  • The last three reported values for Cash & Equivalents were $9.9 billion (Q4 2025), $11.4 billion (Q3 2025), and $9.2 billion (Q2 2025) per Business Quant data.